MedPath

Lilly Del Caribe, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

SFDA:13
PHILIPPINES:8

Drug Approvals

Yulareb

Approval Date
Jul 14, 2025
PHILIPPINES

Yulareb

Approval Date
Jul 14, 2025
PHILIPPINES

Olumiant

Approval Date
Jul 14, 2025
PHILIPPINES

Cialis

Approval Date
Jul 14, 2025
PHILIPPINES

Cymbalta

Approval Date
Jul 14, 2025
PHILIPPINES

Cymbalta

Approval Date
Jul 14, 2025
PHILIPPINES

Olumiant

Approval Date
Jul 14, 2025
PHILIPPINES

Yulareb

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.